Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atomy is a prominent South Korean multi-level marketing company that specializes in the distribution of health supplements, skincare, and personal care products. The company is widely recognized for its flagship product, HemoHim, a functional health supplement developed by the Korea Atomic Energy Research Institute (KAERI) to enhance immune system function and natural killer cell activity. Atomy operates under a "Masstige" business philosophy, which aims to provide products of absolute quality at absolute prices to a global consumer base. While the company does not engage in traditional pharmaceutical drug development, it maintains a strategic partnership with Kolmar BNH for the manufacturing of its health and beauty lines. Since its inception in 2009, Atomy has expanded its footprint to over 20 global markets, including the United States, China, and Southeast Asia. The company consistently ranks among the top direct-selling entities globally by annual revenue.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atomy.